Evaluation of the Bioequivalence of two Linagliptin/Metformin Hydrochloride 2.5/1000 mg Fixed-Dose Combination Tablets in Healthy Adults Under Fed Conditions: A Study from Bangladesh
Journal of Pharmacy and Pharmacology Research · 2025
DOI: 10.26502/fjppr.0116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology Research, 2025. Verfasst von Sabrina Akter Tushi und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tushi, S. A., Rahman, M. A., Bhowmik, U. K., Ghosh, N., Sahana, N. C., & Islam, M. A. (2025). Evaluation of the Bioequivalence of two Linagliptin/Metformin Hydrochloride 2.5/1000 mg Fixed-Dose Combination Tablets in Healthy Adults Under Fed Conditions: A Study from Bangladesh. Journal of Pharmacy and Pharmacology Research. https://doi.org/10.26502/fjppr.0116
Vancouver
Tushi SA, Rahman MA, Bhowmik UK, Ghosh N, Sahana NC, Islam MA. Evaluation of the Bioequivalence of two Linagliptin/Metformin Hydrochloride 2.5/1000 mg Fixed-Dose Combination Tablets in Healthy Adults Under Fed Conditions: A Study from Bangladesh. Journal of Pharmacy and Pharmacology Research. 2025. doi:10.26502/fjppr.0116
BibTeX
@article{Tushi2025,
author = {Tushi, Sabrina Akter and Rahman, Md. Ashiqur and Bhowmik, Uttom Kumar and Ghosh, Nayan and Sahana, Nithon Chandra and Islam, Md. Ashraful},
title = {Evaluation of the Bioequivalence of two Linagliptin/Metformin Hydrochloride 2.5/1000 mg Fixed-Dose Combination Tablets in Healthy Adults Under Fed Conditions: A Study from Bangladesh},
journal = {Journal of Pharmacy and Pharmacology Research},
year = {2025},
doi = {10.26502/fjppr.0116}
}
EUVIMED